Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nerium Biotechnology is a biopharmaceutical company focused on the research, development, and commercialization of products derived from the Nerium oleander plant. The company utilizes a proprietary extraction process to produce NAE-8, a standardized botanical extract with antioxidant and anti-inflammatory properties used in both cosmetic and pharmaceutical applications. Its lead drug candidate, Anvirzel, is a botanical extract containing oleandrin that has been studied in Phase 1 and Phase 2 clinical trials for the treatment of advanced solid tumors and viral diseases. Nerium Biotechnology maintains its own oleander plantations and manufacturing facilities to ensure the quality and consistency of its raw materials. The company is also known for its line of skincare products, which were historically distributed through a partnership with Neora.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nerium Biotechnology.